Angiodynamics (ANGO) Non-Current Deferred Tax Liability (2013 - 2026)

Angiodynamics (ANGO) has 14 years of Non-Current Deferred Tax Liability data on file, last reported at $4.6 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Deferred Tax Liability rose 8.35% year-over-year to $4.6 million; the trailing twelve-month figure through Feb 2026 stood at $4.6 million (up 8.35% YoY), and the FY2025 full-year result was $4.1 million, down 16.06% from the prior year.
• Non-Current Deferred Tax Liability for Q1 2026 stood at $4.6 million, up from $4.3 million in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $17.8 million in Q4 2023 and bottomed at $1.3 million in Q3 2023.
• The 5-year median for Non-Current Deferred Tax Liability is $4.9 million (2024), against an average of $8.8 million.
• The widest annual swing landed in 2023, when Non-Current Deferred Tax Liability tumbled 91.54%; it then surged 261.69% in 2024.
• A 5-year view of Non-Current Deferred Tax Liability shows it stood at $14.3 million in 2022, then grew by 24.27% to $17.8 million in 2023, then sank by 75.59% to $4.3 million in 2024, then decreased by 0.07% to $4.3 million in 2025, then grew by 5.15% to $4.6 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $4.6 million (Q1 2026), $4.3 million (Q4 2025), and $4.3 million (Q3 2025), per Business Quant data.

Peer Comparison